Rebecca Cohen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Investor Relations Contact | - | - |
Career history of Rebecca Cohen
Former positions of Rebecca Cohen
| Companies | Position | Start | End |
|---|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Investor Relations Contact | 2016-12-31 | 2018-06-30 |
| Public Communications Contact | 2016-12-31 | 2018-06-30 | |
| EPIZYME, INC. | Public Communications Contact | - | 2016-04-30 |
Statistics
International
| United States | 4 |
Operational
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Rebecca Cohen
- Experience
